This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Bristol. Active years: 2017-2018.
Company Filing History:
Years Active: 2017-2018
Title: Innovations of Chenfeng Ke in Saccharide Detection
Introduction
Chenfeng Ke is an accomplished inventor based in Bristol, GB. He has made significant contributions to the field of saccharide detection, holding a total of 2 patents. His work focuses on developing innovative compounds that can selectively bind to target saccharides, such as glucose.
Latest Patents
One of Chenfeng Ke's latest patents is titled "Anthracenyl-tetralactam macrocycles and their use in detecting a target saccharide." This patent describes a water-soluble compound that features suitably hydrophilic substituents. These compounds can selectively bind to target saccharides, such as glucose, and exhibit a detectable spectroscopic response to such binding. This innovation enables the detection and correction of blood glucose concentrations in vivo, which is crucial for managing diabetes and other health conditions.
Career Highlights
Chenfeng Ke is affiliated with the University of Bristol, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in medical diagnostics and health monitoring.
Collaborations
Some of his notable coworkers include Anthony Davis and Anthony P Davis. Their collaborative efforts contribute to the ongoing research and development in the field of saccharide detection.
Conclusion
Chenfeng Ke's innovative work in the detection of saccharides represents a significant advancement in medical technology. His contributions have the potential to improve health outcomes for individuals requiring glucose monitoring.